Company / Gross Profit
CHINA PHARMA HOLDINGS, INC. Gross Profit History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
-$131.9K
FY2025
5-year range
-$493.9K / $2.0M
FY2021-FY2025
Trend
+53.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit has fluctuated over the past 10 years, ranging from -$493,916 in FY2022 to $3M in FY2017.
Based on SEC 10-K filings.
-$131,950 in FY2025.
Improved from -$281,085 to -$131,950 over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, gross profit increased 53.1% year-over-year.
- Peak gross profit was recorded in FY2017.
- Lowest gross profit in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$131.9K | +53.1% |
| FY2024 | -$281.1K | +0.0% |
| FY2023 | -$281.1K | +43.1% |
| FY2022 | -$493.9K | -125.3% |
| FY2021 | $2.0M | +31.8% |
| FY2020 | $1.5M | -24.9% |
| FY2019 | $2.0M | -20.0% |
| FY2018 | $2.5M | -23.3% |
| FY2017 | $3.2M | +119.8% |
| FY2016 | $1.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026